These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 30653535)

  • 1. Systematic review of the predictors of statin adherence for the primary prevention of cardiovascular disease.
    Hope HF; Binkley GM; Fenton S; Kitas GD; Verstappen SMM; Symmons DPM
    PLoS One; 2019; 14(1):e0201196. PubMed ID: 30653535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin adherence is lower in primary than secondary prevention: A national follow-up study of new users.
    Sigglekow F; Horsburgh S; Parkin L
    PLoS One; 2020; 15(11):e0242424. PubMed ID: 33211724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-sectional analysis of the prevalence and predictors of statin utilisation in Ireland with a focus on primary prevention of cardiovascular disease.
    Byrne P; Cullinan J; Murphy C; Smith SM
    BMJ Open; 2018 Feb; 8(2):e018524. PubMed ID: 29439070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database.
    Vinogradova Y; Coupland C; Brindle P; Hippisley-Cox J
    BMJ; 2016 Jun; 353():i3305. PubMed ID: 27353261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of statins for the prevention of cardiovascular disease in 41 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data.
    Marcus ME; Manne-Goehler J; Theilmann M; Farzadfar F; Moghaddam SS; Keykhaei M; Hajebi A; Tschida S; Lemp JM; Aryal KK; Dunn M; Houehanou C; Bahendeka S; Rohloff P; Atun R; Bärnighausen TW; Geldsetzer P; Ramirez-Zea M; Chopra V; Heisler M; Davies JI; Huffman MD; Vollmer S; Flood D
    Lancet Glob Health; 2022 Mar; 10(3):e369-e379. PubMed ID: 35180420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin adherence and risk of acute cardiovascular events among women: a cohort study accounting for time-dependent confounding affected by previous adherence.
    Lavikainen P; Helin-Salmivaara A; Eerola M; Fang G; Hartikainen J; Huupponen R; Korhonen MJ
    BMJ Open; 2016 Jun; 6(6):e011306. PubMed ID: 27259530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review.
    De Vera MA; Bhole V; Burns LC; Lacaille D
    Br J Clin Pharmacol; 2014 Oct; 78(4):684-98. PubMed ID: 25364801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin Therapy: Diabetes Mellitus Risk and Cardiovascular Benefit in Primary Prevention.
    Porath A; Arbelle JE; Fund N; Cohen A; Mosseri M
    Isr Med Assoc J; 2018 Aug; 20(8):480-485. PubMed ID: 30084572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review and economic evaluation of statins for the prevention of coronary events.
    Ward S; Lloyd Jones M; Pandor A; Holmes M; Ara R; Ryan A; Yeo W; Payne N
    Health Technol Assess; 2007 Apr; 11(14):1-160, iii-iv. PubMed ID: 17408535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of adherence to statins for primary prevention.
    Mann DM; Allegrante JP; Natarajan S; Halm EA; Charlson M
    Cardiovasc Drugs Ther; 2007 Aug; 21(4):311-6. PubMed ID: 17665294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to statins and its impact on clinical outcomes: a retrospective population-based study in China.
    Zhao B; He X; Wu J; Yan S
    BMC Cardiovasc Disord; 2020 Jun; 20(1):282. PubMed ID: 32522146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formal comment on "Systematic review of the predictors of statin adherence for the primary prevention of cardiovascular disease".
    Diamond DM; de Lorgeril M; Kendrick M; Ravnskov U; Rosch PJ
    PLoS One; 2019; 14(1):e0205138. PubMed ID: 30653537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin-associated incident diabetes: a literature review.
    Park ZH; Juska A; Dyakov D; Patel RV
    Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time to improve statin prescription guidelines in low-risk patients?
    Balder JW; de Vries JK; Mulder DJ; Kamphuisen PW
    Eur J Prev Cardiol; 2017 Jul; 24(10):1064-1070. PubMed ID: 28429651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interventions to Improve Statin Tolerance and Adherence in Patients at Risk for Cardiovascular Disease : A Systematic Review for the 2020 U.S. Department of Veterans Affairs and U.S. Department of Defense Guidelines for Management of Dyslipidemia.
    Reston JT; Buelt A; Donahue MP; Neubauer B; Vagichev E; McShea K
    Ann Intern Med; 2020 Nov; 173(10):806-812. PubMed ID: 32956601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Socioeconomic Inequalities in Statin Adherence Under Universal Coverage: Does Sex Matter?
    Aarnio E; Martikainen J; Winn AN; Huupponen R; Vahtera J; Korhonen MJ
    Circ Cardiovasc Qual Outcomes; 2016 Nov; 9(6):704-713. PubMed ID: 27756795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time trends in statin use and incidence of recurrent cardiovascular events in secondary prevention between 1999 and 2013: a registry-based study.
    Laleman N; Henrard S; van den Akker M; Goderis G; Buntinx F; Van Pottelbergh G; Vaes B
    BMC Cardiovasc Disord; 2018 Nov; 18(1):209. PubMed ID: 30400778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the impact of the recent controversy over statins in France: the EVANS study.
    Saib A; Sabbah L; Perdrix L; Blanchard D; Danchin N; Puymirat E
    Arch Cardiovasc Dis; 2013 Oct; 106(10):511-6. PubMed ID: 24080324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of a Combined Measure of Adherence and Treatment Intensity With Cardiovascular Outcomes in Patients With Atherosclerosis or Other Cardiovascular Risk Factors Treated With Statins and/or Ezetimibe.
    Khunti K; Danese MD; Kutikova L; Catterick D; Sorio-Vilela F; Gleeson M; Kondapally Seshasai SR; Brownrigg J; Ray KK
    JAMA Netw Open; 2018 Dec; 1(8):e185554. PubMed ID: 30646277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does a cardiovascular event change adherence to statin treatment in patients with type 2 diabetes? A matched cohort design.
    de Vries FM; Denig P; Vegter S; Bos HJ; Postma MJ; Hak E
    Curr Med Res Opin; 2015 Apr; 31(4):595-602. PubMed ID: 25629791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.